DYRK1B and metabolic dysfunction-associated steatotic liver disease: Next, we performed expression proteomics in CD-fed Dyrk1bAAV-WT and Dyrk1b–/– liver to identify Dyrk1b-dependent global alterations in the signaling pathways causing NAFLD (Figure 6, A and B).